Odyssey Health, Inc.

Forward-Looking Statements

This communication contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, without limitation, statements regarding the Company’s ability to successfully and timely close the sub-license agreement. These statements are based on management’s current expectations, assumptions, and available information. Forward-looking statements are often identified by words such as “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” and similar expressions that do not relate solely to historical facts. Investors are cautioned not to place undue reliance on these statements, as they are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied. Such risks and uncertainties include, but are not limited to: the Company’s ability to advance the manufacturing and commercialization of BreastCheck™ within anticipated timelines; its ability to secure adequate financing, whether dilutive or non-dilutive; and its expectations regarding the potential benefits, effectiveness, safety, manufacturing, and distribution of BreastCheck™, as well as broader economic and market conditions. Additional risks are detailed in the Company’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements speak only as of the date of this communication, and the Company undertakes no obligation to update them, except as required by law.